This Article Full Text Full Text (PDF) All Versions of this Article: 115/13/1798    most recent CIRCULATIONAHA.106.627570v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hussain, T. Articles by Aurora, P. Search for Related Content PubMed PubMed Citation Articles by Hussain, T. Articles by Aurora, P. Related Collections CV surgery: transplantation, ventricular assistance, cardiomyopathy Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2007;115:1798-1805.)
© 2007 American Heart Association, Inc.

Pediatric Cardiology

Positive Pretransplantation Cytomegalovirus Serology Is a Risk Factor for Cardiac Allograft Vasculopathy in Children

Tarique Hussain, MBBCh, MA, MRCPCH; Michael Burch, MBChB, MD, FRCPCH; Matthew J. Fenton, MBBS, BSc, MRCPCH; Pauline M. Whitmore, RGN, RSCN; Philip Rees, MBBCh, BSc, FRCPCH; Martin Elliott, MBBS, MD, FRCS; Paul Aurora, MBBS, BSc, MSc, MRCPCH

From Paediatric Cardiology, Great Ormond Street Hospital, London, United Kingdom.

Correspondence to Tarique Hussain, 14A Ledcameroch Rd, Bearsden, G61 4AB, United Kingdom. E-mail tarique{at}doctors.org.uk

Received April 21, 2006; accepted December 21, 2006.

Background— Cytomegalovirus (CMV) infection has been implicated as a cause of posttransplantation coronary artery disease in adults. The purpose of this retrospective observational study was to evaluate the effect of CMV on outcome after heart transplantation in children.

Methods and Results— Risk factors tested were recipient age, sex, and pretransplantation CMV serology; use of anti-CMV prophylaxis; posttransplantation evidence of CMV infection; and donor CMV serology. Transplantations were stratified traditionally according to CMV risk as low risk (recipient negative/donor negative), intermediate risk (recipient positive), and high risk (recipient negative/donor positive). Primary outcome measures were (1) development of coronary artery vasculopathy, (2) mortality (or graft loss) that occurred outside the early postoperative period, and (3) death (or graft loss) due to vasculopathy. Analysis was by proportional hazards modeling. A total of 165 children underwent heart transplantation, with a mean age at transplantation of 7.8 (SD 5.6) years. Thirty-two children had laboratory evidence of CMV infection after transplantation, but only 6 developed CMV disease or syndrome. Traditional CMV risk stratification correlated well with CMV infection but did not predict mortality, coronary artery disease, or coronary death. In contrast, positive recipient CMV was the only independent predictor of all 3 outcome measures: coronary artery disease (hazard ratio=3.6), all-cause mortality (partial hazard ratio=4.1), and coronary death (hazard ratio=4.6).

Conclusions— In children, pretransplantation recipient CMV status is a more powerful predictor for the development of clinically significant vasculopathy and subsequent death than traditional risk stratification. This phenomenon warrants further investigation.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				J. Simmonds, M. Fenton, C. Dewar, E. Ellins, C. Storry, D. Cubitt, J. Deanfield, N. Klein, J. Halcox, and M. Burch Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation Circulation, May 20, 2008; 117(20): 2657 - 2661. [Abstract] [Full Text] [PDF]

				S. Arora, P. A. Jenum, P. Aukrust, H. Rollag, A. K. Andreassen, S. Simonsen, E. Gude, A. E. Fiane, O. Geiran, and L. Gullestad Reply J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1827 - 1828. [Full Text] [PDF]

				S. Arora, P. A. Jenum, P. Aukrust, H. Rollag, A. K. Andreassen, S. Simonsen, E. Gude, A. E. Fiane, O. Geiran, and L. Gullestad Pre-Transplant Toxoplasma gondii Seropositivity Among Heart Transplant Recipients Is Associated With an Increased Risk of All-Cause and Cardiac Mortality J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1967 - 1972. [Abstract] [Full Text] [PDF]